Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Selleck Chemical LLC Inbrx-105-A4023-1MG
Supplier: Selleck Chemical LLC A40231MG
Inbrx-105 is a recombinant humanized bispecific antibody targeting programmed death-ligand 1 (PD-L1) and 4-1BB with potential checkpoint inhibitory immunostimulating and antineoplastic activities By binding to 4-1BB on activated T lymphocytes and PD-L1 on tumor cells INBRX-105 enhances T-cell co-stimulation and inhibits PD-L1-mediated T-cell inhibition potentially leading to reduced tumor growth INBRX-105 exhibits antitumor efficacy and increased T-cell frequency in patients with solid tumors and in in-vivo MW 101 9 KD
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction